Angus Liu is a senior writer at Fierce Pharma, currently leading the publication’s oncology coverage, and he also writes about cancer drugs and China-related topics for Fierce Biotech. Angus has reported extensively on oncology, including the rise of checkpoint inhibitors, cell therapies and antibody-drug conjugates. Angus earned his Master’s at Northwestern University’s Medill School of Journalism.
Speaking In
11:00 AM - 12:00 PM
Wednesday, June 7
10:15 AM - 11:15 AM
Thursday, June 8
